Distrbution and risk factors analysis of infections caused by extended-spectrum β-lactamase-producing Escherichia coli
10.3969/j.issn.1673-4130.2017.15.012
- VernacularTitle:产超广谱β-内酰胺酶大肠埃希菌感染分布及危险因素分析
- Author:
Wenping ZHANG
;
Feidi YE
;
Wenjie LAI
;
Zhongming ZHANG
;
Shan CHEN
;
Shasha HUANG
;
Jianting ZHANG
;
Xuan ZENG
;
Qiuping ZHANG
- Keywords:
extended-spectrum β-lactamase;
Escherichia coli;
nosocomial infection;
risk factor
- From:
International Journal of Laboratory Medicine
2017;38(15):2048-2050
- CountryChina
- Language:Chinese
-
Abstract:
Objective To analyze the specimen types,ward distribution and risk factors for infections caused by extended-spectrum β-lactamase(ESBLs)-producing-Escherichia coli(ECO) in recent two years,so as to provide bacteriological basis for both hospital infection control and clinical anti-infection treatment.Methods Non-repetitive 443 ECO strains isolated from the hospitalized patients in the Third People′s Hospital of Shenzhen were collcted,and the phoenix100 system was employed for bacterial identification and antimicrobial susceptibility tests.ESBLs-ECO was further confirmed by the double-disk synergy test,and the risk factors caused ESBLs-ECO were statistically analyzed.Results A total of 115 strains of ESBLs-ECO were identified among the 443 strains of ECO,which accounted for 26.0%.The ESBLs-ECO strains were mainly isolated from the sputum,urine,and blood specimens.Among the isolated ESBLs-ECO strains,20.9% were isolated from the department of Tuberculosis,13.9% from the department of pediatric,12.2% from the department of live disease,and 8.7% from the department of infection.The male sex,surgery and use of the third generation cephalosporins were independent risk factors of ESBLs-ECO infection.Conclusion The isolation rate of ESBLs-ECO in this hospital is high.It is necessary for the hospital to strengthen the control of nosocomial infections according to the risk factors.More attention should be payed on male patients,the standardization of surgical operation and disinfection,and the restriction of using the third generation cephalosporins,so as to reduce the incidene of ESBLs-ECO infections.
